17
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Curcumin inhibits hepatitis C virus replication via suppressing the Akt-SREBP-1 pathway.

      Febs Letters
      Anti-Inflammatory Agents, Non-Steroidal, pharmacology, Antiviral Agents, Cell Line, Tumor, Curcumin, Drug Synergism, Gene Expression Regulation, Viral, drug effects, Hepacivirus, genetics, growth & development, Humans, Interferon-alpha, NF-kappa B, metabolism, Phosphatidylinositol 3-Kinases, Proto-Oncogene Proteins c-akt, RNA Interference, Reverse Transcriptase Polymerase Chain Reaction, Signal Transduction, Sterol Regulatory Element Binding Protein 1, Transcription Factor RelA, Viral Nonstructural Proteins, Virus Replication

      Read this article at

      ScienceOpenPublisherPubMed
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          A polyphenolic compound from the curry spice turmeric, curcumin, is known to show anti-viral activity against the influenza virus, adenovirus, coxsackievirus, and the human immunodeficiency virus. However, it remains to be determined whether curcumin can inhibit the replication of hepatitis C virus (HCV). In this study, we showed that curcumin decreases HCV gene expression via suppression of the Akt-SREBP-1 activation, not by NF-kappaB pathway. The combination of curcumin and IFNalpha exerted profound inhibitory effects on HCV replication. Collectively, our results indicate that curcumin can suppress HCV replication in vitro and may be potentially useful as novel anti-HCV reagents. Copyright 2009 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.

          Related collections

          Author and article information

          Comments

          Comment on this article

          Related Documents Log